Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3055 of 6351
-
Phone app may help track and treat social anxiety
Symptom relief CompletedThe goal of this study is to examine if a digital behavior-based framework, utilizing the BHQ app, can effectively monitor social anxiety symptoms and evaluate the symptom-reducing impact of attentional training for adults (18-65) with social anxiety disorder (SAD), compared to t…
Sponsor: Tel Aviv University • Aim: Symptom relief
Last updated Jun 26, 2026 14:34 UTC
-
Can mirror therapy ease chronic pain better than standard rehab?
Symptom relief CompletedComplex Regional Pain Syndrome (CRPS) is a chronic pain condition characterized by persistent pain, sensory disturbances, motor dysfunction, and functional impairment, often following trauma or surgery. Conventional physical therapy is commonly used in the management of CRPS; how…
Sponsor: University of Lahore • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Can peer support keep drug users in the ER and save lives?
Symptom relief Recruiting nowMany people with high-risk opioid use visit emergency departments (EDs), facing a high risk of death if they leave before completing care. Peer support workers (Peer) - people with lived experience of substance use - may improve patient comfort, reduce early departures, and poten…
Sponsor: University of British Columbia • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Cancer drug cabozantinib tested in kids and young adults with bone cancer
Disease control Stopped earlyThe participants of this study will be children, adolescents, and young adults with residual osteosarcoma, which cannot be removed completely through surgery. Participants will have achieved a partial response or stable disease at the end of conventional chemotherapy. Osteosarco…
Phase 2 • Sponsor: Ipsen • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Jail-to-Community HIV and addiction care gets a tech boost
Knowledge-focused CompletedThe goal of this clinical study in one NY county is to pilot and refine implementation strategies aimed at improving delivery and uptake of evidence-based practices (EBPs) for HIV prevention/treatment and substance use disorder (SUD) care among incarcerated individuals approachin…
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Brain zaps aim to lift apathy in schizophrenia
Symptom relief Recruiting nowThis research aims to test the effectiveness of Navigated transcranial magnetic stimulation (nTMS) of left Supramarginal Gyrus for negative symptoms. In this double-blind, randomized controlled trial, patients will be assigned to active iTBS experimental group or sham iTBS group.…
Sponsor: Central South University • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Eating by the clock: a new way to stabilize bipolar moods?
Symptom relief Recruiting nowThe goal of this clinical trial is to understand how level of adherence with time-restricted eating (TRE) predicts change in diurnal rhythms (as measured using the amplitude of diurnal peripheral clock gene expression), and how those changes predict lower mania and depressive sym…
Sponsor: University of California, Berkeley • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New PET scan could spot hidden heart infections
Diagnosis CompletedCiGal-EI-TEP is an exploratory study that aim to assess the diagnostic performance of 68Ga Positron emission tomography (PET) / Computed Tomography (CT) for the diagnosis of prosthetic valve infective endocarditis in comparison with the final diagnosis established according to th…
Phase 2 • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Aug 29, 2026 00:00 UTC
-
New drug aims to boost growth in kids with noonan syndrome
Disease control Recruiting nowThe purpose of this study in children with Noonan syndrome is to evaluate the effect of 3 doses of vosoritide on growth as measured by AGV after 6 months of treatment. The long-term efficacy and safety of vosoritide at the therapeutic dose will be evaluated up to FAH.
Phase 2 • Sponsor: BioMarin Pharmaceutical • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Spine surgery showdown: which fix keeps teens moving best?
Disease control CompletedThe aim of this study is to evaluate the short, medium and long-term efficacy and safety of vertebral body tethering, based on the results obtained at 3-5 months of follow-up, exploring not only the ability to correct scoliosis, but also the safety and ability to preserve the nat…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Brain training for better mood control: new study tests N-ACT program
Symptom relief CompletedThe goal of this clinical trial is to test a new cognitive training program to improve emotion regulation in adults. The investigators' primary aim is to determine whether participating in this program addresses two key features of emotion dysregulation associated with psychiatri…
Sponsor: University of California, Berkeley • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Simple IV drip may prevent painful complication after common bile duct procedure
Prevention Recruiting nowThis study will explore the efficacies of several practical short-term (peri-procedural) intravenous fluid regimens in the prevention of post- endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP). PEP is the most common serious ERCP-related adverse event (AE),…
Phase 4 • Sponsor: University of Calgary • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC
-
New global registry aims to unlock secrets of rare heart rhythm disorder
Knowledge-focused Recruiting nowCalcium Release Deficiency Syndrome (CRDS) is a newly discovered genetic arrhythmia syndrome that confers a risk of life-threatening arrhythmias secondary to RYR2 loss-of-function. The International CRDS registry has been designed to facilitate large-scale evaluation of CRDS, inc…
Sponsor: Population Health Research Institute • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Could a nerve zap cure sleep apnea? early trial recruits in latin america
Disease control Recruiting nowThe purpose of this study is to characterize the upper airway of Latin American subjects who have been diagnosed with moderate/severe obstructive sleep apnea (OSA) and assess response to a neuromodulation therapy to treat OSA.
Early phase 1 • Sponsor: Lunair Medical • Aim: Disease control
Last updated Jun 26, 2026 13:23 UTC
-
Smartphone beats could steady Parkinson's steps
Symptom relief CompletedParkinson's Disease (PD) is a major cause of disability, globally. PD affects a person's movement speed, fluency, quality, and ease of walking. PD has the fastest-growing incidence rate, with its prevalence expected to double over the next three decades, currently affecting 10 mi…
Sponsor: Northumbria University • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Could your own immune cells fight ALS? early trial begins
Disease control Recruiting nowAn open, multi- center phase Ⅰ clinical study evaluating the safety and efficacy of autologous human polyclonal regulatory T cell injection (NP001 cell injection) in patients with Neurodegenerative diseases (ALS).
Phase 1 • Sponsor: Novabio Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can a drug and a stent change bladder cancer recovery?
Disease control Recruiting nowThe purpose of this study is to look at two standard surgical techniques used during a radical cystectomy and see whether they influence outcomes such as length of stay in the hospital and infections after surgery. This trial will evaluate whether the following surgical methods i…
Phase 3 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug DSB2455 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowOpen label, multi-centre, Phase Ia/b adaptive design study with an initial 2-stage Dose Escalation Phase followed by a Dose Expansion Phase.
Phase 1 • Sponsor: Duke Street Bio Ltd • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New radioactive compound shows promise in targeting Hard-to-Treat cancers
Disease control CompletedThis is a single-center, non-randomized, single-arm, open-label exploratory clinical study of ¹⁷⁷Lu-CTR-FAPI in patients with FAP-high expressing metastatic solid tumors, with a focus on breast cancer, sarcoma, and thyroid cancer. The purpose of this study is to evaluate the saf…
Early phase 1 • Sponsor: Lanzhou University Second Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Needle vs. scalpel: which dialysis access works best?
Disease control OngoingPatients with end-stage kidney disease (ESKD) who use hemodialysis to filter their blood require vascular access for the dialysis machine; the most common type of vascular access is called an arteriovenous fistula (AVF). The AVF is a direct connect between an artery and vein. Un…
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC